Valeant Pharmaceuticals said chief executive Michael Pearson has returned from medical leave to lead the company, and the embattled Canadian drugmaker moved to split its chief executive and chairman roles.
from WSJ.com: US Business http://ift.tt/1pjg2pQ
via IFTTT
No comments:
Post a Comment